Navigation Links
delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
Date:8/21/2009

SOUTH BURLINGTON, Vt., Aug. 4 /PRNewswire-FirstCall/ -- delSECUR CORPORATION, a Nevada Corporation, (Pink Sheets: DLSC) announced today that its Board of Directors has accepted, subject to the approval of the majority of the shareholders entitled to vote, an agreement to purchase the Intellectual Property Assets of delSECUR CORPORATION. The consideration for such purchase will be in the form of a 49% interest in the shares of common stock of Q Tech Systems, Inc., an Ontario, Canada Corporation.

The primary asset to be acquired by Q Tech is the del-ID technology, a patented device and system of authenticating individuals through biometric means invented by Pierre de Lanauze, the former President & CEO of delSECUR. Q Tech, which also develops and markets technologies to enhance security and identification processes, plans to incorporate the del-ID technology with its proprietary technology. "Q Tech will be immediately focusing on the invention of Pierre de Lanauze's analog technology and believes it can make this combined technology commercially viable and bring it to the marketplace," said Randall McCormick, delSECUR's current CEO.

Mr. McCormick further stated, "We believe this is a great opportunity for the advancement of the del-ID technology and puts our business plan and mission statement immediately into action without further delay.

It is time to bring the del-Id technology to the next level and to test its capabilities. With this new alliance we are much closer to that goal."

delSECUR, a public company (Pink Sheets: DLSC) with its head office in S. Burlington, VT., is a technology development company of a unique authentication process based on abstract images of biological data collected from the fingers of living persons.

For further information contact us at: investorrelations@delsecur.com

This Press Release may contain forward-looking statements. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and other similar statements. Statements that are not historical facts, including statements relating to anticipated future earnings, margins, and other operating results, future growth, construction plans and anticipated capacities, production schedules and entry into expanded markets are forward-looking statements. Such forward-looking statements, based upon the current beliefs and expectations of our management, are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements and are subject to the risks normally associated with the completions of a corporate transaction. The information set forth herein should be read in light of such risks. We assume no obligation to update the information contained in this press release, except as required under applicable law.


'/>"/>
SOURCE delSECUR CORPORATION
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
2. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
3. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
4. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
5. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
6. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
7. Carbon Disclosure Project: Worlds largest corporations seek clarity on climate change regulation
8. L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation
9. Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results
10. Corporations can profit from being environmentally friendly
11. Communication Intelligence Corporation Closes $3.6 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/25/2016)... -- Glencoe Software, the world-leading supplier of image data management ... the data management solution OMERO Plus for the newly ... Photo - http://photos.prnewswire.com/prnh/20160125/325328LOGO ... Phenotypic analysis measures the characteristics and behavior of cells, ... such as health and disease, the presence or absence ...
(Date:1/22/2016)... 2016 http://www.researchandmarkets.com/research/p74whf/global_biometrics ... "Global Biometrics Market in Retail Sector ... --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has announced ... Market in Retail Sector 2016-2020" report ... Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has ...
(Date:1/20/2016)... -- A market that just keeps on growing. Molecular ... in genomics knowledge. Learn all about it in this ... dynamic trends are pushing market growth and company valuations. ... - pathogen evolution - next generation sequencing - emergence ... of the role of genetic material in Disease and ...
Breaking Biology News(10 mins):
(Date:2/12/2016)... Biocom, the association representing the Southern California ... San Diego companies to Washington D.C. ... Fly-In. Biocom Fly-In participants had the opportunity to meet with ... for Medicare and Medicaid Services (CMS), the National Institutes of ... Susan Davis and Scott Peters to discuss ...
(Date:2/12/2016)... Feb. 12, 2016  BD (Becton, Dickinson and Company) ... company, today announced the launch of the BD CLiC™ ... Technology (AGBT) Meeting. --> ... research by providing cost effective NGS library preparation with ... high-throughput, fully integrated, next generation sequencing (NGS) library prep ...
(Date:2/12/2016)... SAN FRANCISCO , February 12, 2016 /PRNewswire/ ... Precision Medicine Efforts by Enabling Scientific Understanding of ... Disorders and Rare Diseases --> ... for genomic diagnostics in South Asia and a leading ... it would contribute $10 million to the GenomeAsia ...
(Date:2/11/2016)... Inc. (NASDAQ: NBIX ) today announced its financial results for ... --> --> For the fourth quarter of ... $0.34 loss per share, compared to a net loss of $19.4 ... 2014. For the year ended December 31, 2015, the Company reported ... as compared to a net loss of $60.5 million, or $0.81 ...
Breaking Biology Technology: